Translational advances in pancreatic ductal adenocarcinoma therapy
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer that is most frequently detected at advanced stages, limiting treatment options to systemic chemotherapy with modest clinical responses. Here, we review recent advances in targeted therapy and immunotherapy for treating subtypes of PDAC...
Main Authors: | Aguirre, A.J (Author), Dougan, S.K (Author), Hosein, A.N (Author), Maitra, A. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Research
2022
|
Online Access: | View Fulltext in Publisher |
Similar Items
-
Photodynamic Therapy for Pancreatic Ductal Adenocarcinoma
by: Vida Karimnia, et al.
Published: (2021-08-01) -
Locally Advanced Pancreatic Ductal Adenocarcinoma: Challenges and Progress
by: Barcellini A, et al.
Published: (2020-12-01) -
Advanced Pancreatic Ductal Adenocarcinoma: Moving Forward
by: Caspar Franck, et al.
Published: (2020-07-01) -
Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma
by: Jia-qiao Fan, et al.
Published: (2020-02-01) -
Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies
by: Aleksandra Adamska, et al.
Published: (2017-06-01)